Phase I Study of a Novel Oral Janus Kinase 2 Inhibitor, SB1518, in Patients With Relapsed Lymphoma: Evidence of Clinical and Biologic Activity in Multiple Lymphoma Subtypes

por Younes, Anas, Romaguera, Jorge, Fanale, Michelle, McLaughlin, Peter, Hagemeister, Frederick, Copeland, Amanda, Neelapu, Sattva, Kwak, Larry, Shah, Jatin, de Castro Faria, Silvana, Hart, Stefan, Wood, Jeanette, Jayaraman, Ramesh, Ethirajulu, Kantharaj, Zhu, Joy
Publicado en J Clin Oncol (2012)

Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma

por Oki, Yasuhiro, Buglio, Daniela, Fanale, Michelle, Fayad, Luis, Copeland, Amanda, Romaguera, Jorge, Kwak, Larry W., Pro, Barbara, de Castro Faria, Silvana, Neelapu, Sattva, Fowler, Nathan, Hagemeister, Fredrick, Zhang, Jiexin, Zhou, Shouhao, Feng, Lei, Younes, Anas
Publicado en Clin Cancer Res (2013)